By leveraging a hardware-software platform, NeuroDetect creates diagnostic and therapeutic biomarker profiles to aid in the detection and treatment of epilepsy. Their innovative approach involves the use of diagnostic biomarkers to identify the presence of the disease and predictive biomarkers to determine individuals who are likely to respond well to specific medical treatments. With a focus on advancing precision-guided therapies, NeuroDetect aims to improve patient outcomes and provide personalized care for those suffering from epilepsy.